FinnAStraughnAMeyerMChubbJ. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopham Drug Dispos1987; 8: 519–26.
2.
LangCCMorelandTADaveyPG. Methods of assessing bioavailability of cefuroxime axetil, an oral cephalosporin. Br J Clin Pharmacol1989; 282: 237P–8P.
3.
GwaltneyJM. Sinusitis. In: MandellGLDouglasRGBennettJE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 510–4.
4.
SydnorAGwaltneyJMCocchettoDMScheldM. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute maxillary sinusitis. Arch Otolaryngol Head Neck Surg1989; 115: 1430–3.
5.
McLinnSEWernerKCocchettoDM. Clinical trial of cefuroxime axetil versus cefaclor for acute otitis media with effusion. Curr Ther Res1988; 43: 1–11.
6.
AronovitzGH. Treatment of otitis media with cefuroxime axetil. South Med J1988; 81: 978–80.
7.
Physicians' desk reference. 43rd ed.Oradell, NJ: Medical Economics, 1989: 598.
8.
Physicians' desk reference. 44th ed.Oradell, NJ: Medical Economics, 1990: 595.